Healthspan vs Lifespan: Why the 9.6-Year Gap Matters More Than Your Age

Direct Answer: Lifespan is the total number of years a person lives. Healthspan is the number of those years spent in good health, free from significant disability or chronic disease burden. Across 183 countries, people now spend an average of 9.6 years of their life in poor health. Longevity science focuses on narrowing this gap: not simply adding years to life, but preserving the quality and function of those years.¹

Key Takeaways

• The global healthspan-lifespan gap now stands at an average of 9.6 years, meaning most people spend nearly a decade of their life in poor health before death.¹
• The United States has the largest recorded healthspan-lifespan gap of any high-income nation, reaching 12.4 years, driven primarily by rising noncommunicable diseases.¹
• Women globally face a gap 2.4 years wider than men on average, suggesting that greater longevity does not automatically confer equivalent health quality in later life.¹
• Research from large prospective cohorts suggests that adopting multiple healthy lifestyle factors in midlife is associated with substantially more years lived free of major chronic disease.²
• Biological age, measured through tools such as epigenetic clocks, can diverge meaningfully from chronological age and appears to be influenced by modifiable lifestyle factors including diet and exercise.^3,4
• Morbidity compression, the goal of shortening the period of functional decline at end of life, is a central objective in modern longevity research, though achieving it at a population level remains a significant challenge.
• Where supplementation fits: certain compounds studied for their roles in cellular energy, oxidative balance, and DNA maintenance are currently being investigated in the context of healthspan support, though human evidence in this area continues to develop.

Chapter 1: Understanding the Healthspan-Lifespan Distinction

For most of human history, the central preoccupation in public health was a simple one: keeping people alive for as long as possible. Life expectancy improved dramatically across the twentieth century, driven by advances in sanitation, nutrition, vaccinations, and medical care. That progress has continued into the twenty-first century, with average global life expectancy reaching historic highs.

Yet in parallel, a quieter and more uncomfortable question has emerged: what is the quality of those additional years?

The concept of healthspan addresses this question directly. While lifespan refers to the total duration of a person's life, healthspan refers to the proportion of that life spent in good functional health, free from the kind of chronic disease burden or significant disability that substantially diminishes daily experience and independence.

Health economists and epidemiologists measure healthspan using a metric called Health-Adjusted Life Expectancy, or HALE. HALE discounts years of life by the degree of functional impairment experienced during those years. A year spent with severe physical disability, for instance, counts as considerably less than a year of full health. The difference between a person's overall life expectancy and their HALE is the morbidity gap: the number of years, on average, that they can expect to spend in compromised health before death.

This distinction is not merely academic. For individuals, it determines the realistic horizon of active, engaged, independent living. For healthcare systems, it shapes long-term costs and the sustainability of elder care. For longevity science, closing the morbidity gap has become at least as important an objective as extending total lifespan.

Chapter 2: The 9.6-Year Morbidity Gap: What the Data Shows

In late 2024, a large cross-sectional study published in JAMA Network Open quantified the healthspan-lifespan gap across all 183 World Health Organization member states using two decades of longitudinal WHO Global Health Observatory data. The findings were striking.¹

Globally, the mean healthspan-lifespan gap had widened over the preceding twenty years and now stands at an average of 9.6 years. In practical terms, this means that across the world's populations, a substantial final chapter of life is spent not in the full health and vitality of earlier decades, but managing one or more significant health conditions.¹

The data revealed notable variation by geography and sex. The United States recorded the largest healthspan-lifespan gap of any high-income nation, at 12.4 years. Researchers identified a significant association between this widening gap and the rising burden of noncommunicable diseases, particularly cardiovascular conditions, metabolic disorders, and musculoskeletal diseases.¹

A sex disparity was also documented: women globally experienced a healthspan-lifespan gap averaging 2.4 years wider than men, a finding the authors linked to a disproportionately greater burden of noncommunicable diseases in women later in life. While women tend to live longer than men on average, this data suggests that longer life does not necessarily translate into a proportionally longer period of good health.¹

Morbidity Compression: The Central Goal

The concept of morbidity compression was first formalised in 1980 by epidemiologist James Fries, who proposed that with appropriate health interventions, the period of functional decline and significant illness at end of life could be compressed into a shorter and shorter window, even as overall lifespan extended. In an ideal scenario, a person would enjoy full or near-full function for the great majority of their life, then decline and die within a relatively brief final period.

Current evidence suggests that while some compression has been achieved in specific populations, a true population-level compression of morbidity has been difficult to demonstrate consistently. Many researchers describe the present trend as "expansion of morbidity" rather than compression: people are living longer, but a growing proportion of those additional years involve chronic disease burden. The implication is that without deliberate, targeted intervention, gains in lifespan do not automatically confer equivalent gains in healthspan.

Country Comparisons and Blue Zone Populations

Certain populations and regions provide natural laboratories for studying healthspan extension. The so-called Blue Zones, regions such as Okinawa in Japan, Sardinia in Italy, and Nicoya in Costa Rica, have long attracted attention because their inhabitants not only live longer than average but often maintain functional health well into advanced age. Researchers have documented characteristic lifestyle patterns in these populations: high levels of habitual physical activity, plant-rich diets, strong social cohesion, and clear sense of purpose.

Whether the Blue Zone model can be translated to general populations is debated, and some specific demographic data from these regions has been questioned in recent years. However, they remain influential conceptual frameworks for understanding what sustained healthspan, rather than merely extended lifespan, might look like at a population level.

Chapter 3: What Shortens Healthspan: The Key Drivers

Understanding what creates the morbidity gap requires looking at the conditions that most commonly account for years lived in poor health. The Global Burden of Disease Study, which tracks disability-adjusted life years (DALYs) and HALE across hundreds of conditions and geographies, consistently identifies a cluster of noncommunicable diseases as the principal drivers of the healthspan-lifespan gap in high-income countries.⁵

Cardiovascular Disease

Cardiovascular conditions, including coronary artery disease, heart failure, and stroke, remain the single largest contributor to years lived with disability and to premature death globally. Importantly, most cardiovascular disease is considered highly preventable. Key risk factors including hypertension, dyslipidaemia, insulin resistance, smoking, and physical inactivity are all potentially modifiable. The degree to which cardiovascular burden can be reduced through lifestyle intervention is one of the most robustly evidenced areas in preventive health research.

Metabolic Dysfunction

Type 2 diabetes and its precursor states represent a growing global burden, closely linked to rising rates of obesity and sedentary behaviour. Metabolic dysfunction is particularly relevant to healthspan because it frequently acts as an upstream driver of multiple downstream conditions: cardiovascular disease, kidney disease, vision impairment, neuropathy, and increased infection risk. The metabolic syndrome cluster, combining excess visceral adiposity, insulin resistance, elevated blood pressure, and dyslipidaemia, is associated with substantially accelerated biological aging rates in human studies.

Cognitive Decline

Age-related cognitive decline, from mild impairment to dementia, constitutes one of the most feared and health-burden-heavy aspects of aging for many populations. Dementia currently affects tens of millions of people globally and is projected to rise sharply in coming decades. While pharmacological treatments remain limited in scope, there is accumulating evidence that modifiable risk factors including physical activity, sleep quality, cardiovascular health, and social engagement each play meaningful roles in long-term cognitive trajectories.

Musculoskeletal Conditions

Conditions such as osteoarthritis, osteoporosis, and sarcopenia (progressive loss of muscle mass and strength) are the largest single contributors to years lived with disability globally according to GBD analyses. These conditions severely compromise mobility, independence, and quality of life. Critically, they are not simply inevitable consequences of aging: physical activity levels, nutritional adequacy, and hormonal status each influence their onset and progression. Sarcopenia in particular has emerged as a key predictor of functional decline, falls, and loss of independence in older adults.

What connects these conditions is that each has a substantial modifiable component. None arises purely from genetic determinism, and for each, human evidence exists linking behavioural and nutritional factors to either risk reduction or slower progression.

Chapter 4: Biological Age vs Chronological Age: The Bridge Concept

Chronological age is simply the number of calendar years that have passed since a person's birth. It is uniform, fixed, and tells us very little about an individual's actual physiological state. Two people aged 55 can have dramatically different health profiles, organ function, cognitive performance, and future disease risk.

Biological age attempts to capture what is actually happening at the cellular and molecular level, independently of the calendar. It asks: how rapidly is this body aging? And can that rate be measured, tracked, and potentially influenced?

Epigenetic Clocks

Among the most scientifically advanced tools for estimating biological age are epigenetic clocks. These are computational models that analyse DNA methylation patterns, the biochemical marks that regulate gene expression across the genome. As humans age, characteristic and measurable changes occur in these methylation patterns. By analysing hundreds or thousands of specific sites in the genome, researchers can generate an estimate of biological age that, in many studies, predicts health outcomes and mortality risk more accurately than chronological age alone.

Multiple generations of epigenetic clock have been developed, including Horvath's original pan-tissue clock, GrimAge, DunedinPACE, and others. Each has different predictive properties: some are better calibrated to all-cause mortality risk, others to specific disease trajectories or pace-of-aging estimates.

The key finding that makes epigenetic clocks relevant to healthspan science is that biological age, as measured by these clocks, is not fixed by genetics. It appears to be influenced by lifestyle exposures. A 2021 randomised controlled trial conducted among 43 healthy adult males aged 50 to 72 found that an 8-week program combining dietary guidance, moderate exercise, sleep support, and stress reduction was associated with a statistically significant reduction in biological age of approximately 3.23 years compared with control participants, as measured by the Horvath DNAmAge clock.³ The authors described this as a pilot study with a relatively small sample size and called for larger replication trials, but the findings represented an early signal that deliberate lifestyle intervention might measurably shift biological aging rates in humans.³

Separate observational research has found that dietary quality is inversely associated with epigenetic age acceleration. An analysis of over 2,600 participants found that higher scores on multiple validated healthy eating indices were significantly associated with lower epigenetic age acceleration across multiple clock measures, with the strongest associations observed for phenotypic age and GrimAge.⁴

Other Biomarkers of Biological Age

Beyond epigenetic clocks, a range of other physiological markers are studied as indicators of biological aging rate. Telomere length, a measure of the protective caps on chromosomes that shorten with each cell division, has long been associated with aging and disease risk in human cohort studies, though the relationship is complex and causality remains debated. Physiological parameters such as grip strength, gait speed, forced vital capacity, resting heart rate variability, and metabolic markers offer more immediately clinically accessible estimates of functional biological age.

The emerging consensus is that biological age is not a single number but a multidimensional construct, and that no single biomarker can capture it comprehensively. Multi-omics approaches, integrating methylation, proteomics, metabolomics, and other data layers, represent the current frontier of biological age assessment research.

Chapter 5: Evidence-Based Strategies to Maximise Healthspan

If the healthspan-lifespan gap is substantially driven by modifiable lifestyle factors, the practical question becomes: what does the human evidence actually say about which interventions work?

A landmark prospective cohort study drawing on data from over 110,000 participants in the Nurses' Health Study and Health Professionals Follow-up Study with up to 34 years of follow-up found that adherence to five low-risk lifestyle behaviours, including not smoking, maintaining a healthy body weight, regular moderate-to-vigorous physical activity, moderate alcohol intake, and a high-quality diet, was associated with substantially extended life expectancy in both men and women. Those who adhered to all five behaviours were estimated to have a life expectancy at age 50 approximately 12 to 14 years longer than those who adhered to none.²

A follow-up analysis from the same cohort examined not just total life expectancy but years lived free of major chronic disease: cardiovascular disease, type 2 diabetes, and cancer. Women at age 50 who adopted four or five of these healthy habits were estimated to live approximately 34.4 years free of these conditions, compared with approximately 23.7 years for those who adopted none. Equivalent gains were observed in men.⁶ These estimates represent associations from observational data and cannot be interpreted as establishing direct causation, but they are supported by a large and consistent body of evidence across multiple independent cohorts.

Physical Activity

Of all the lifestyle factors associated with extended healthspan, habitual physical activity has perhaps the most robust and consistent evidence base. Regular aerobic and resistance exercise is associated with reduced risk of cardiovascular disease, metabolic dysfunction, cognitive decline, and musculoskeletal deterioration. For older adults, maintaining muscle mass and strength through resistance training appears to be a particularly important determinant of functional independence. Evidence from human cohort studies consistently links higher physical activity levels to reduced all-cause and cause-specific mortality, to lower rates of disability, and to preserved cognitive function in later life.

Sleep Quality

Chronic insufficient or fragmented sleep has emerged as an important and underappreciated driver of accelerated biological aging and increased chronic disease risk. Human studies have linked consistently short sleep duration (below approximately 7 hours per night in adults) and poor sleep quality to elevated inflammatory markers, insulin resistance, cardiovascular risk, and impaired cognitive function. Sleep is now recognised as a period of critical biological maintenance: glymphatic clearance of metabolic waste from the brain, cellular repair processes, hormonal regulation, and immune function all depend substantially on adequate sleep architecture.

Nutritional Quality

Dietary patterns consistently emerge as significant modifiers of healthspan in human research. Rather than focusing on individual nutrients, current evidence places stronger weight on overall dietary patterns. Mediterranean-style diets, characterised by high intake of vegetables, legumes, whole grains, olive oil, fish, and moderate polyphenol-rich foods, have been associated with reduced cardiovascular risk, better cognitive trajectories, and lower rates of metabolic dysfunction in large prospective cohort studies. The mechanisms under study include effects on systemic inflammation, gut microbiome composition, oxidative balance, and insulin sensitivity.

Stress Management and Social Connection

Psychological stress and social isolation have increasingly been recognised as physiologically significant factors in aging trajectories. Chronic psychological stress activates glucocorticoid pathways that have downstream effects on immune function, inflammatory signalling, and even epigenetic aging rates. Social connection, conversely, is one of the most consistently identified correlates of healthy longevity across Blue Zone and large cohort research. The mechanisms through which social engagement supports healthspan are multiple, including effects on motivation, cognitive stimulation, stress buffering, and health behaviours.

Where Supplementation Fits

Supplementation is best understood as a complement to, rather than a substitute for, the foundational lifestyle factors described above. However, within a well-established lifestyle foundation, certain nutrient sufficiencies play documented roles in cellular processes relevant to healthy aging.

Several micronutrients have EFSA-approved health claims for functions directly relevant to healthspan-supporting processes. Zinc contributes to normal DNA synthesis. Vitamin C, zinc, and selenium contribute to protection of cells from oxidative stress. Magnesium, vitamin B12, and folate contribute to normal cell division. B vitamins including B1, B3, B6, and B12 contribute to normal energy-yielding metabolism and to normal nervous system function. These are regulatory physiological contributions, not therapeutic claims, but they describe the nutritional substrate on which cellular maintenance depends.

Among ingredients currently attracting research interest in the context of NAD+ metabolism and cellular energy dynamics, compounds such as NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are being studied in human trials. These are early-stage areas of human research and the evidence base continues to develop, but they represent an example of how ingredient science intersects with the broader healthspan agenda. For a deeper review of the current evidence on NAD+ precursors, see our dedicated article on this topic.

Questions and Answers

What is the difference between healthspan and lifespan?

Lifespan refers to the total number of years a person lives. Healthspan is the subset of those years spent in good functional health, without significant chronic disease burden or disability. A person can have a long lifespan but a comparatively short healthspan if the final years of life are spent managing multiple serious health conditions.¹

How large is the healthspan-lifespan gap globally?

A 2024 analysis of WHO data from 183 member states found that the global mean healthspan-lifespan gap has widened over the past two decades and now stands at approximately 9.6 years. This means that on average, people spend nearly a decade of their lives in poor health before death. The US gap is larger still, at 12.4 years.¹

Why is the healthspan-lifespan gap widening?

The primary driver identified in research is the rising burden of noncommunicable diseases, particularly cardiovascular conditions, metabolic dysfunction, and musculoskeletal disorders. As populations age and life expectancy increases, a growing proportion of people are living with one or more of these chronic conditions for extended periods, expanding the years spent in compromised health relative to total years lived.¹

Is it possible to increase healthspan through lifestyle choices?

Human cohort research suggests a meaningful association between healthy lifestyle patterns and extended disease-free life expectancy. A major prospective study found that adhering to multiple healthy lifestyle factors at midlife was associated with an estimated 10 to 14 additional years of life expectancy, and with substantially more years lived free of major chronic diseases such as cardiovascular disease, type 2 diabetes, and cancer.² These are associations from observational research and do not establish direct causation.

What is biological age and how does it relate to healthspan?

Biological age is an estimate of a person's actual physiological state, independent of their calendar age. It can be measured using tools such as epigenetic clocks, which analyse DNA methylation patterns to estimate the rate at which a body is aging. Biological age is relevant to healthspan because it may predict health trajectories and disease risk more accurately than chronological age, and because early research suggests it can be influenced by lifestyle factors including diet and exercise.^3,4

What is morbidity compression and why does it matter?

Morbidity compression describes a scenario in which the period of significant chronic illness and disability before death is shortened, even as overall lifespan increases. Rather than spending an extended period in poor health, a person would maintain good function for most of their life and decline only briefly. This is considered a central goal of longevity science, though achieving it at a population level remains a challenge given current trends in noncommunicable disease burden.

Do women have a different healthspan-lifespan gap than men?

Research indicates that women globally experience a healthspan-lifespan gap approximately 2.4 years wider than men on average, despite the fact that women tend to have a longer overall lifespan. This suggests that while women live longer, a greater proportion of their additional years are spent with significant health burden, particularly from noncommunicable diseases. The underlying mechanisms are complex and likely involve a combination of biological, hormonal, and social factors.¹

How do epigenetic clocks work as a measure of biological aging?

Epigenetic clocks are computational models built from patterns of DNA methylation, the addition and removal of chemical marks on DNA that regulate gene expression. As humans age, specific sites in the genome undergo predictable methylation changes. By measuring hundreds or thousands of these sites, researchers can generate a biological age estimate. Multiple clock types have been developed, each calibrated to different health outcomes. These tools are used in research settings to study aging trajectories and to evaluate the potential impact of interventions.³

Frequently Asked Questions

References

1. Garmany A, Yamada S, Terzic A. Global Healthspan-Lifespan Gaps Among 183 World Health Organization Member States. JAMA Netw Open. 2024;7(12):e2451269. View on PubMed ↗
2. Li Y, Pan A, Wang DD, Liu X, Dhana K, Franco OH, Stampfer M, Willett WC, Manson J, Giovannucci E, Hu FB. Impact of Healthy Lifestyle Factors on Life Expectancies in the US Population. Circulation. 2018;138(4):345-355. View on PubMed ↗
3. Fitzgerald KN, Hodges R, Hanes D, Stack E, Cheishvili D, Szyf M, Henkel J, Twedt MW, Giannopoulou D, Herdell J, Logan S, Bradley R. Potential reversal of epigenetic age using a diet and lifestyle intervention: a pilot randomized clinical trial. Aging (Albany NY). 2021;13(7):9419-9432. View on PubMed ↗
4. Kresovich JK, Park YMM, Keller JA, Sandler DP, Taylor JA. Healthy eating patterns and epigenetic measures of biological age. Am J Clin Nutr. 2022;115(1):171-179. View on PubMed ↗
5. GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories, 1990-2021. Lancet. 2024;403(10440):2133-2161. View on PubMed ↗
6. Li Y, Schoufour J, Wang DD, Dhana K, Pan A, Liu X, Song M, Liu G, Shin HJ, Sun Q, Al-Shaar L, Wang M, Rimm EB, Hertzmark E, Stampfer MJ, Willett WC, Franco OH, Hu FB. Healthy lifestyle and life expectancy free of cancer, cardiovascular disease, and type 2 diabetes: prospective cohort study. BMJ. 2020;368:l6669. View on PubMed ↗
7. GBD 2015 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1603-1658. View on PubMed ↗